PTJ
CVS icon

Paul Tudor Jones’s CVS Health CVS Stock Holding History

Paul Tudor Jones’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.2M Buy
127,600
+26,400
+26% +$2.36M 0.02% 691
2026
Q1 		$7.27M Sell
101,200
-51,800
-34% -$3.99M 0.01% 939
2025
Q4 		$12.1M Buy
153,000
+62,300
+69% +$4.91M 0.02% 621
2025
Q3 		$6.84M Sell
90,700
-19,800
-18% -$1.36M 0.01% 993
2025
Q2 		$7.62M Buy
110,500
+86,800
+366% +$5.69M 0.02% 816
2025
Q1 		$1.61M Sell
23,700
-478,400
-95% -$28.6M 0.01% 1491
2024
Q4 		$22.5M Buy
502,100
+205,900
+70% +$11.6M 0.09% 133
2024
Q3 		$18.6M Buy
296,200
+42,400
+17% +$2.47M 0.07% 197
2024
Q2 		$15M Buy
253,800
+147,800
+139% +$9.25M 0.08% 243
2024
Q1 		$8.45M Sell
106,000
-226,400
-68% -$17.3M 0.05% 418
2023
Q4 		$26.2M Buy
332,400
+112,000
+51% +$7.97M 0.21% 68
2023
Q3 		$15.4M Buy
220,400
+67,500
+44% +$4.78M 0.15% 104
2023
Q2 		$10.6M Buy
152,900
+135,900
+799% +$9.67M 0.13% 160
2023
Q1 		$1.26M Buy
+17,000
New +$1.43M 0.02% 1048
2022
Q1 		– Sell
-2,200
Closed -$226K – 2126
2021
Q4 		$226K Buy
+2,200
New +$203K ﹤0.01% 2073
2016
Q2 		– Sell
-47,500
Closed -$4.93M – 1678
2016
Q1 		$4.93M Buy
+47,500
New +$4.62M 0.13% 123

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Paul Tudor Jones's CVS Position: Q2 2026 in Review

Paul Tudor Jones reduced its CVS Health (CVS) stake by 46% in Q2 2026, selling an estimated $27.8M and leaving 370,000 shares worth $38.3M. The position accounts for 0.05% of the portfolio, ranked #260.

Paul Tudor Jones first reported a position in CVS in Q2 2013 and has held it in 37 quarters since. The position peaked at $49M in Q1 2026. 2,059 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Paul Tudor Jones held 370,000 shares of CVS Health worth $38.3M as of Q2 2026.
  • Paul Tudor Jones sold 311,806 CVS Health shares in Q2 2026, an estimated $27.8M.
  • CVS Health made up 0.05% of Paul Tudor Jones's portfolio in Q2 2026, its #260 holding.
  • Paul Tudor Jones first reported a position in CVS Health in Q2 2013 and has held it in 37 quarters since.
  • Paul Tudor Jones's CVS Health position peaked at $49M in Q1 2026.
  • 2,059 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.